The estimated Net Worth of Andrea Ellis is at least $336 Thousand dollars as of 15 March 2022. Andrea Ellis owns over 12,000 units of BridgeBio Pharma Inc stock worth over $335,880 and over the last 3 years Andrea sold BBIO stock worth over $0.
Andrea has made over 1 trades of the BridgeBio Pharma Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently Andrea bought 12,000 units of BBIO stock worth $100,680 on 15 March 2022.
The largest trade Andrea's ever made was buying 12,000 units of BridgeBio Pharma Inc stock on 15 March 2022 worth over $100,680. On average, Andrea trades about 2,400 units every 0 days since 2021. As of 15 March 2022 Andrea still owns at least 12,000 units of BridgeBio Pharma Inc stock.
You can see the complete history of Andrea Ellis stock trades at the bottom of the page.
Andrea's mailing address filed with the SEC is C/O BRIDGEBIO PHARMA, INC., 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304.
Over the last 5 years, insiders at BridgeBio Pharma Inc have traded over $409,396,563 worth of BridgeBio Pharma Inc stock and bought 12,280,644 units worth $209,241,115 . The most active insiders traders include Global Investors Lp Viking ..., Andrew Lo, and Genetic Disorder L.P.Kkr Ge.... On average, BridgeBio Pharma Inc executives and independent directors trade stock every 12 days with the average trade being worth of $4,173,197. The most recent stock trade was executed by Neil Kumar on 16 August 2024, trading 55,537 units of BBIO stock currently worth $1,554,481.
we focus on accelerating and maximizing value in early-stage, genetic disease assets by applying our management expertise and proprietary platform. our team picks the right assets based on our systematic mapping of the genetic disease landscape, and develops those assets with the right approach, supporting r&d with expert capabilities and placing them in a value maximizing corporate structure.
BridgeBio Pharma Inc executives and other stock owners filed with the SEC include: